RegentAtlantic Capital’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

RegentAtlantic Capital’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,180	Closed	-$34K	–	393
2015 Q4	$34K	Hold	4,180	–	–	﹤0.01%	370
2015 Q3	$30K	Hold	4,180	–	–	﹤0.01%	366
2015 Q2	$38K	Hold	4,180	–	–	﹤0.01%	371
2015 Q1	$39K	Hold	4,180	–	–	﹤0.01%	359
2014 Q4	$40.7K	Hold	4,180	–	–	﹤0.01%	627
2014 Q3	$40K	Hold	4,180	–	–	﹤0.01%	363
2014 Q2	$55K	Hold	4,180	–	–	0.01%	358
2014 Q1	$56K	Hold	4,180	–	–	0.01%	353
2013 Q4	$41K	Hold	4,180	–	–	﹤0.01%	352
2013 Q3	$41K	Hold	4,180	–	–	﹤0.01%	334
2013 Q2	$38K	Buy	+4,180	New	+$43.8K	﹤0.01%	329

Other funds holding CDMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RegentAtlantic Capital's CDMO Position: Q1 2016 in Review

RegentAtlantic Capital sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2016, closing a stake of 4,180 shares — an estimated $34K sold.

RegentAtlantic Capital first reported a position in CDMO in Q2 2013 and held it in 11 quarters. The position peaked at $56K in Q1 2014. 84 funds tracked by Wall St. Rank hold CDMO as of Q1 2016.

RegentAtlantic Capital reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
RegentAtlantic Capital sold 4,180 Avid Bioservices, Inc. Common Stock shares in Q1 2016, an estimated $34K.
RegentAtlantic Capital first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 11 quarters.
RegentAtlantic Capital's Avid Bioservices, Inc. Common Stock position peaked at $56K in Q1 2014.
84 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2016.

Based on RegentAtlantic Capital's 13F filing for Q1 2016, filed 22 Apr 2016.